• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PAQR3在人类乳腺癌中的表达下调,并与HER2表达相关。

PAQR3 expression is downregulated in human breast cancers and correlated with HER2 expression.

作者信息

Li Zhenghu, Ling Zhi-Qiang, Guo Weiwei, Lu Xiao-Xiao, Pan Yi, Wang Zhenzhen, Chen Yan

机构信息

Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Graduate School of the Chinese Academy of Sciences, Shanghai, China.

Zhejiang Cancer Research Institute, Zhejiang Province Cancer Hospital, Zhejiang Cancer Center, China.

出版信息

Oncotarget. 2015 May 20;6(14):12357-68. doi: 10.18632/oncotarget.3657.

DOI:10.18632/oncotarget.3657
PMID:25900239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4494943/
Abstract

PAQR3 is a newly discovered tumor suppressor and its functional role in breast cancer has not been well characterized. We report here that PAQR3 is associated with the progression and survival of human patients with breast cancer, as well as cell proliferation and migration of human breast cancer cells. PAQR3 mRNA level was robustly downregulated in human breast cancer samples compared with their corresponding para-cancerous histological normal tissues (n = 82, P < 0.0001). The mRNA level of PAQR3 was negatively correlated with HER2 expression (P < 0.0001) and disease-free survival of the patients (P < 0.0001). PAQR3 overexpression inhibited cell proliferation, colony formation and migration of breast cancer cells including MCF7, SKBR3, MDA-MD-231, MDA-MD-468 and MDA-MD-453 cells. Knockdown of PAQR3 in MDA-MD-231 cells elevated cell proliferation and migration. Inhibition of HER2 by trastuzumab increased PAQR3 expression in SKBR3 cells. In conclusion, PAQR3 expression is frequently downregulated in human breast cancers inversely correlated with HER2 expression. PAQR3 is able to modulate the proliferation and migration of breast cancer cells. Our data indicate that PAQR3 functions as a tumor suppressor in the development of human breast cancers.

摘要

PAQR3是一种新发现的肿瘤抑制因子,其在乳腺癌中的功能作用尚未得到充分阐明。我们在此报告,PAQR3与人类乳腺癌患者的病情进展和生存情况相关,也与人类乳腺癌细胞的增殖和迁移有关。与相应的癌旁组织学正常组织相比,PAQR3 mRNA水平在人类乳腺癌样本中显著下调(n = 82,P < 0.0001)。PAQR3的mRNA水平与HER2表达呈负相关(P < 0.0001),与患者的无病生存期也呈负相关(P < 0.0001)。PAQR3过表达抑制了包括MCF7、SKBR3、MDA-MD-231、MDA-MD-468和MDA-MD-453细胞在内的乳腺癌细胞的增殖、集落形成和迁移。在MDA-MD-231细胞中敲低PAQR3可提高细胞增殖和迁移能力。曲妥珠单抗抑制HER2可增加SKBR3细胞中PAQR3的表达。总之,PAQR3表达在人类乳腺癌中经常下调,与HER2表达呈负相关。PAQR3能够调节乳腺癌细胞的增殖和迁移。我们的数据表明,PAQR3在人类乳腺癌发生发展中起肿瘤抑制作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e96/4494943/9607075799e5/oncotarget-06-12357-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e96/4494943/16c7cc449ef8/oncotarget-06-12357-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e96/4494943/219c6a055840/oncotarget-06-12357-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e96/4494943/bece7aae38e0/oncotarget-06-12357-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e96/4494943/5c865637a1dc/oncotarget-06-12357-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e96/4494943/da4a682652fc/oncotarget-06-12357-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e96/4494943/9607075799e5/oncotarget-06-12357-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e96/4494943/16c7cc449ef8/oncotarget-06-12357-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e96/4494943/219c6a055840/oncotarget-06-12357-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e96/4494943/bece7aae38e0/oncotarget-06-12357-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e96/4494943/5c865637a1dc/oncotarget-06-12357-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e96/4494943/da4a682652fc/oncotarget-06-12357-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e96/4494943/9607075799e5/oncotarget-06-12357-g006.jpg

相似文献

1
PAQR3 expression is downregulated in human breast cancers and correlated with HER2 expression.PAQR3在人类乳腺癌中的表达下调,并与HER2表达相关。
Oncotarget. 2015 May 20;6(14):12357-68. doi: 10.18632/oncotarget.3657.
2
MiR-15b facilitates breast cancer progression via repressing tumor suppressor PAQR3.miR-15b 通过抑制肿瘤抑制因子 PAQR3 促进乳腺癌的进展。
Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):740-748. doi: 10.26355/eurrev_202001_20054.
3
The role of PAQR3 gene promoter hypermethylation in breast cancer and prognosis.PAQR3基因启动子高甲基化在乳腺癌及预后中的作用
Oncol Rep. 2016 Sep;36(3):1612-8. doi: 10.3892/or.2016.4951. Epub 2016 Jul 19.
4
Upregulation of MIIP regulates human breast cancer proliferation, invasion and migration by mediated by IGFBP2.MIIP 的上调通过 IGFBP2 介导调节人乳腺癌的增殖、侵袭和迁移。
Pathol Res Pract. 2019 Jul;215(7):152440. doi: 10.1016/j.prp.2019.152440. Epub 2019 May 6.
5
Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma.鉴定PAQR3为肝细胞癌中一种新的候选肿瘤抑制因子。
Oncol Rep. 2014 Dec;32(6):2687-95. doi: 10.3892/or.2014.3532. Epub 2014 Oct 6.
6
A Golgi-specific protein PAQR3 is closely associated with the progression, metastasis and prognosis of human gastric cancers.一种高尔基体特异性蛋白 PAQR3 与人胃癌的进展、转移和预后密切相关。
Ann Oncol. 2014 Jul;25(7):1363-1372. doi: 10.1093/annonc/mdu168. Epub 2014 May 5.
7
Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells.Erythropoietin 受体表达及其与曲妥珠单抗反应和耐药性在 HER2 阳性乳腺癌细胞中的关系。
Breast Cancer Res Treat. 2012 Dec;136(3):739-48. doi: 10.1007/s10549-012-2316-x. Epub 2012 Nov 2.
8
PAQR3 inhibits the proliferation, migration and invasion in human glioma cells.PAQR3抑制人胶质瘤细胞的增殖、迁移和侵袭。
Biomed Pharmacother. 2017 Aug;92:24-32. doi: 10.1016/j.biopha.2017.05.046. Epub 2017 May 18.
9
PAQR3 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer Cells.PAQR3抑制食管癌细胞的增殖和肿瘤发生。
Oncol Res. 2017 May 24;25(5):663-671. doi: 10.3727/096504016X14761384026719.
10
The tumor suppressor role of PAQR3 in osteosarcoma.PAQR3在骨肉瘤中的肿瘤抑制作用。
Tumour Biol. 2015 May;36(5):3319-24. doi: 10.1007/s13277-014-2964-z. Epub 2014 Dec 17.

引用本文的文献

1
Downregulation of PAQR3 expression predicts poor prognosis of patients with pan-cancer: a meta-analysis.PAQR3表达下调预示泛癌患者预后不良:一项荟萃分析
Front Oncol. 2025 May 5;15:1574150. doi: 10.3389/fonc.2025.1574150. eCollection 2025.
2
The Emerging Roles and Mechanisms of PAQR3 in Human Cancer: Pathophysiology and Therapeutic Implications.PAQR3在人类癌症中的新兴作用和机制:病理生理学及治疗意义
Int J Gen Med. 2023 Sep 22;16:4321-4328. doi: 10.2147/IJGM.S422523. eCollection 2023.
3
PAQR3 Inhibits Non-small Cell Lung Cancer Growth by Regulating the NF-κB/p53/Bax Axis.

本文引用的文献

1
HER2 and HER3 cooperatively regulate cancer cell growth and determine sensitivity to the novel investigational EGFR/HER2 kinase inhibitor TAK-285.HER2和HER3协同调节癌细胞生长,并决定对新型研究性EGFR/HER2激酶抑制剂TAK-285的敏感性。
Oncoscience. 2014 Mar 24;1(3):196-204. doi: 10.18632/oncoscience.23. eCollection 2014.
2
Targeting HER2(+) breast cancer: the TBK1/IKKε axis.靶向HER2(+)乳腺癌:TBK1/IKKε轴
Oncoscience. 2014 Mar 6;1(2):180-2. doi: 10.18632/oncoscience.18. eCollection 2014.
3
Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma.
PAQR3通过调节NF-κB/p53/Bax轴抑制非小细胞肺癌生长。
Front Cell Dev Biol. 2020 Oct 6;8:581919. doi: 10.3389/fcell.2020.581919. eCollection 2020.
4
PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation.PAQR4 通过抑制 Nrf2 蛋白降解促进非小细胞肺癌的化疗耐药性。
Theranostics. 2020 Feb 19;10(8):3767-3778. doi: 10.7150/thno.43142. eCollection 2020.
5
Characterization of the Golgi scaffold protein PAQR3, and its role in tumor suppression and metabolic pathway compartmentalization.高尔基体支架蛋白PAQR3的表征及其在肿瘤抑制和代谢途径区室化中的作用。
Cancer Manag Res. 2020 Jan 16;12:353-362. doi: 10.2147/CMAR.S210919. eCollection 2020.
6
PAQR3 suppresses the growth of non-small cell lung cancer cells via modulation of EGFR-mediated autophagy.PAQR3 通过调节 EGFR 介导的自噬来抑制非小细胞肺癌细胞的生长。
Autophagy. 2020 Jul;16(7):1236-1247. doi: 10.1080/15548627.2019.1659654. Epub 2019 Aug 30.
7
Suppressor PAQR3 associated with the clinical significance and prognosis in esophageal squamous cell carcinoma.抑制因子PAQR3与食管鳞状细胞癌的临床意义及预后相关。
Oncol Lett. 2018 Apr;15(4):5703-5711. doi: 10.3892/ol.2018.8004. Epub 2018 Feb 8.
8
PAQR3 suppresses the proliferation, migration and tumorigenicity of human prostate cancer cells.PAQR3抑制人前列腺癌细胞的增殖、迁移和致瘤性。
Oncotarget. 2016 Jun 3;8(33):53948-53958. doi: 10.18632/oncotarget.9807. eCollection 2017 Aug 15.
9
[Expression and Clinical Significance of Progesterone and Adiponectin Receptor Family Member 3 in Lung Cancer].[孕酮和脂联素受体家族成员3在肺癌中的表达及临床意义]
Zhongguo Fei Ai Za Zhi. 2017 Apr 20;20(4):259-263. doi: 10.3779/j.issn.1009-3419.2017.04.06.
10
PAQR3 regulates Golgi vesicle fission and transport via the Gβγ-PKD signaling pathway.PAQR3通过Gβγ-PKD信号通路调节高尔基体囊泡的裂变和运输。
Cell Signal. 2015 Dec;27(12):2444-51. doi: 10.1016/j.cellsig.2015.08.017. Epub 2015 Aug 29.
鉴定PAQR3为肝细胞癌中一种新的候选肿瘤抑制因子。
Oncol Rep. 2014 Dec;32(6):2687-95. doi: 10.3892/or.2014.3532. Epub 2014 Oct 6.
4
A Golgi-specific protein PAQR3 is closely associated with the progression, metastasis and prognosis of human gastric cancers.一种高尔基体特异性蛋白 PAQR3 与人胃癌的进展、转移和预后密切相关。
Ann Oncol. 2014 Jul;25(7):1363-1372. doi: 10.1093/annonc/mdu168. Epub 2014 May 5.
5
The immune system and response to HER2-targeted treatment in breast cancer.乳腺癌中免疫系统与针对 HER2 靶向治疗的反应。
Lancet Oncol. 2014 Feb;15(2):e58-68. doi: 10.1016/S1470-2045(13)70477-7.
6
Survival of HER2-Positive Breast Cancer Cells: Receptor Signaling to Apoptotic Control Centers.人表皮生长因子受体2阳性乳腺癌细胞的存活:受体信号传导至凋亡控制中心。
Genes Cancer. 2013 May;4(5-6):187-95. doi: 10.1177/1947601913488598.
7
PAQR3 has modulatory roles in obesity, energy metabolism, and leptin signaling.PAQR3 在肥胖、能量代谢和瘦素信号中具有调节作用。
Endocrinology. 2013 Dec;154(12):4525-35. doi: 10.1210/en.2013-1633. Epub 2013 Sep 13.
8
Activating HER2 mutations in HER2 gene amplification negative breast cancer.在 HER2 基因扩增阴性乳腺癌中激活 HER2 突变。
Cancer Discov. 2013 Feb;3(2):224-37. doi: 10.1158/2159-8290.CD-12-0349. Epub 2012 Dec 7.
9
PAQR3 plays a suppressive role in the tumorigenesis of colorectal cancers.PAQR3 在结直肠癌细胞的肿瘤发生中起抑制作用。
Carcinogenesis. 2012 Nov;33(11):2228-35. doi: 10.1093/carcin/bgs245. Epub 2012 Jul 24.
10
Current approaches and future directions in the treatment of HER2-positive breast cancer.当前治疗 HER2 阳性乳腺癌的方法和未来方向。
Cancer Treat Rev. 2013 May;39(3):219-29. doi: 10.1016/j.ctrv.2012.04.008. Epub 2012 May 31.